Regenxbio (RGNX) EPS (Basic) Growth (5y) (2019 - 2025)
Regenxbio (RGNX) EPS (Basic) Growth (5y) (2019 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Regenxbio | 528.62 Mn | 298.55 Mn | 21.22 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 27.76% |
| Sep 30, 2025 | -49.15% |
| Jun 30, 2025 | -8.73% |
| Mar 31, 2025 | 15.59% |
| Dec 31, 2024 | -13.28% |
| Sep 30, 2024 | -4.72% |
| Jun 30, 2024 | -93.18% |
| Mar 31, 2024 | -12.78% |
| Dec 31, 2023 | -67.48% |
| Sep 30, 2023 | -377.87% |
| Jun 30, 2023 | -449.61% |
| Mar 31, 2023 | -241.97% |
| Dec 31, 2022 | 69.73% |
| Sep 30, 2022 | -382.23% |
| Jun 30, 2022 | -407.02% |
| Mar 31, 2022 | -364.69% |
| Dec 31, 2021 | 62.50% |
| Sep 30, 2021 | -14.84% |
| Jun 30, 2021 | -19.88% |
| Mar 31, 2021 | -24.00% |